Acute intracardiac thrombosis and pulmonary thromboembolism after cardiopulmonary bypass: A systematic review of reported cases

Anesthesia and Analgesia

Volumn 126, Issue 2, 2017, Pages 425-434

  Williams, Brittney ^a   Wehman, Brody ^a   Mazzeffi, Michael A ^a   Odonkor, Patrick ^a   Harris, Ryan L ^b   Kon, Zachary ^a   Tanaka, Kenichi A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AMINOCAPROIC ACID; APROTININ; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

AORTIC TRAUMA; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONGESTIVE HEART FAILURE; CRYOPRECIPITATE; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; META ANALYSIS; MORTALITY RATE; PLASMA TRANSFUSION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBECTOMY; THROMBOCYTE TRANSFUSION; THROMBOPHILIA; TREATMENT DURATION; ADULT; AGED; CASE REPORT; FEMALE; HEART DISEASE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; THROMBOSIS; TRENDS;

ADULT; AGED; CARDIOPULMONARY BYPASS; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; THROMBOSIS;

EID: 85022065028     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000002259     Document Type: Article

References (87)

1. Fergusson DA, Hébert PC, Mazer CD, et al; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319-2331.
2. Alström U, Levin LÅ, Ståhle E, Svedjeholm R, Friberg O. Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery. Br J Anaesth. 2012;108:216-222.
3. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial. Anesthesiology. 2013;118:40-50.
4. Green JA, Spiess BD. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America. 2003;21:527-251.
5. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis. CMAJ. 2009;180:183-193.
6. Ogawa S, Richardson JE, Sakai T, Ide M, Tanaka KA. High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass. J Anesth. 2012;26:9-19.
7. Bagot CN, Arya R. Virchow and his triad: A question of attribution. Br J Haematol. 2008;143:180-190.
8. Saffitz JE, Stahl DJ, Sundt TM, Wareing TH, Kouchoukos NT. Disseminated intravascular coagulation after administration of aprotinin in combination with deep hypothermic circulatory arrest. Am J Cardiol. 1993;72:1080-1082.
9. Gitter R, Alivizators P, Capehart J, Ramsay M, Jett GK. Aprotinin and aortic cannula thrombosis. J Thorac Cardiovasc Surg. 1996;112:537-538.
10. Alvarez JM, Goldstein J, Mezzatesta J, Flanagan B, Dodd M. Fatal intraoperative pulmonary thrombosis after graft replacement of an aneurysm of the arch and descending aorta in association with deep hypothermic circulatory arrest and aprotinin therapy. J Thorac Cardiovasc Surg. 1998;115:723-724.
11. Köhler M, Hellstern P, Lechler E, Uberfuhr P, Müller-Berghaus G. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost. 1998;80:399-402.
12. Fanashawe MP, Shore-Lesserson L, Reich DL. Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. Anesthesiology. 2001;95:1525-1527.
13. Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002;124:852-854.
14. Ramsey M, Marcel R, Capehart J, Cheung EH, Ring WS. Massive intravascular thrombosis and thromboembolism after cardiopulmonary bypass. Internet J Thorac Cardiovasc Surg. 2002;5:13326.
15. Legare JF, Arora R, Wood JW. Massive intracavitary clot formation during cardiopulmonary bypass. Can J Cardiol. 2004;20:825-826.
16. Augoustides JG, Lin J, Gambone AJ, Cheung AT. Fatal thrombosis in an adult after thoracoabdominal aneurysm repair with aprotinin and deep hypothermic circulatory arrest. Anesthesiology. 2005;103:215-216.
17. Simek M, Nemec P, Cermák M, Prikrylová K. Intraoperative massive pulmonary embolism during coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2005;4:283-284.
18. Augoustides JG, Kilbaugh T, Harris H, Glick JH, Acker M, Savino JS. Fatal thrombosis after mitral valve replacement for endocarditis: Aprotinin and disseminated intravascular coagulation. Anesthesiology. 2006;104:213.
19. Cooper JR Jr, Abrams J, Frazier OH, et al. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: Possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg. 2006;131:963-968.
20. Kottenberg-Assenmacher E, Volbracht L, Jakob H, Greinacher A, Peters J. Disseminated intravascular clotting associated with Fc-receptor IIa-mediated platelet activation in a patient with endocarditis after aortic valve replacement. Br J Anaesth. 2006;97:630-633.
21. Schmitz A, Hartmann M. Acute intracardiac thrombus formation during thoracoabdominal aortic surgery. Anesth Analg. 2006;102:1658-1659.
22. Shore-Lesserson L, Reich DL. A case of severe diffuse venous thromboembolism associated with aprotinin and hypothermic circulatory arrest in a cardiac surgical patient with factor V Leiden. Anesthesiology. 2006;105:219-221.
23. Stone ME, Silverman SH, Nomoto K. Intracardiac thrombosis and acute right ventricular failure following complex reoperative cardiac surgery with aprotinin and deep hypothermic circulatory arrest. Semin Cardiothorac Vasc Anesth. 2007;11:177-184.
24. Lichtman AD, Carullo V, Minhaj M, Karkouti K. Case 6-2007: Massive intraoperative thrombosis and death after recombinant activated factor VII administration. J Cardiothorac Vasc Anesth. 2007;21:897-902.
25. Neira VM, Sawchuk C, Bonneville KS, Chu V, Warkentin TE. Case report: Management of immediate post-cardiopulmonary bypass massive intra-cardiac thrombosis. Can J Anaesth. 2007;54:461-466.
26. Horstman DJ, van der Starre PJ. Detection of intracardiac thrombosis after factor VIII inhibitor bypass activity administration by transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2007;21:561-563.
27. Swaminathan M, Shaw AD, Greenfield RA, Grichnik KP. Fatal thrombosis after factor VII administration during extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2008;22:259-260.
28. Apostolidou I, Sweeney MF, Missov E, Joyce LD, John R, Prielipp RC. Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia. Anesth Analg. 2008;106:404-408.
29. Shuhaiber JH, Gunnar W. Intra-cardiac thrombosis following aortic valve replacement. J Card Surg. 2008;23:552.
30. Syburra T, Lachat M, Genoni M, Wilhelm MJ. Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation. Ann Thorac Surg. 2010;89:1643-1645.
31. Trigo P, Stone ME, Fisher G. A patient presenting for concurrent thoracoabdominal aortic aneurysm repair and left ventricular assist device placement (abstract). 33rd Annual Meeting of Society of Cardiovascular Anesthesiologists, Savannah, GA, 2011.
32. Lukauskis K, Banks D. Factor IX complex: Help or harm?. 33rd Annual Meeting of Society of Cardiovascular Anesthesiologists, Savannah, GA, 2011.
33. Corcoran W, D'Ambra M. Acute bioprosthetic thrombosis and coronary embolim during aortic valve replacement. 33rd Annual Meeting of Society of Cardiovascular Anesthesiologists, Savannah, GA, 2011.
34. Kim SY, Song JW, Jang YS, Kwak YL. Formation of intracardiac thrombus during cardiopulmonary bypass despite full heparinization and adequate activated clotting time - A case report-. Korean J Anesthesiol. 2012;62:571-574.
35. Kim SH, Ryu JS, Kim TY, Yoon TG, Kang W, Song JE. Abrupt formation of intracardiac thrombus during cardiopulmonary bypass with full heparinization - A case report. Korean J Anesthesiol. 2012;62:175-178.
36. Jeffcoat A, Despotis GJ. Intracardiac thrombosis after cardiopulmonary bypass status post orthotopic heart transplant (abstract). 34th Annual Meeting of Society of Cardiovascular Anesthesiologists, Boston, MA, 2012.
37. Lee DH, Jung TE, Park SJ. Acute post-cardiopulmonary bypass left atrial thrombosis after mitral valvuloplasty and left atrial thrombectomy. J Cardiothorac Surg. 2012;7:5.
38. Senarslan O, Zungur M, Uyar IS, Uyar S, Tavli T, Alayunt EA. Diagnosis of a huge right atrial thrombus during coronary artery bypass graft surgery. Am J Case Rep. 2013;14:388-390.
39. Ploppa A, Haeberle L, Schmid E, Nohe B. Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth. 2013;27:744-748.
40. Koster A, Meyer-Jark T, Schirmer U, Sandica E. Fulminant intraoperative right heart and pulmonary artery thrombosis following prothrombin complex concentrate infusion after complex open heart surgery with cardiopulmonary bypass. A A Case Rep. 2014;2:89-91.
41. Guruswamy J, Koenig C, Cooper R, Polyak P. Fatal massive intracardiac thrombosis: Unexpected complication during repair of complex aortic dissection with pseudoaneurysm. ASA Annual Meeting, San Diego, CA, 2015.
42. Nielsen VG, Paidy SR, Meek CA, Thornton TK, Lick SD. Survival after intravenous thrombin prior to cardiopulmonary bypass. Int J Legal Med. 2017;131:485-487.
43. Karkouti K, McCluskey SA, Syed S, Pazaratz C, Poonawala H, Crowther MA. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: A prospective observational study. Anesth Analg. 2010;110:1533-1540.
44. Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: Management of two cases using fractionated components and factor VIIa. Anesth Analg. 2007;104:763-765.
45. Sniecinski RM, Chen EP, Tanaka KA. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis. 2008;19:178-179.
46. Hashimoto K, Yamagishi M, Sasaki T, Nakano M, Kurosawa H. Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg. 1994;58:799-804.
47. Levy JH, Despotis GJ, Szlam F, Olson P, Meeker D, Weisinger A. Recombinant human transgenic antithrombin in cardiac surgery: A dose-finding study. Anesthesiology. 2002;96:1095-1102.
48. Chandler WL, Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood. 2003;101:4355-4362.
49. Donahue BS, Gailani D, Mast AE. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass. J Thromb Haemost. 2006;4:1011-1016.
50. Sohn RH, Deming CB, Johns DC, et al. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood. 2005;105:3910-3917.
51. Speekenbrink RG, Bertina RM, España F, Wildevuur CR, Eijsman L. Activation of the protein C system during cardiopulmonary bypass with and without aprotinin. Ann Thorac Surg. 1998;66:1998-2002.
52. Paparella D, Rotunno C, Guida P, et al. Hemostasis alterations in patients with acute aortic dissection. Ann Thorac Surg. 2011;91:1364-1369.
53. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial. J Thorac Cardiovasc Surg. 2010;140:1117-1124.e2.
54. Fassl J, Matt P, Eckstein F, et al. Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: Effect of thromboelastometry-guided transfusion management. J Cardiothorac Vasc Anesth. 2013;27: 1181-1188.
55. Schrezenmeier H, Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?. Vox Sang. 2010;99:1-15.
56. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:815-823.
57. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;103:879-887.
58. Monković DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem. 1990;265:17132-17140.
59. Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood. 1995;86:1794-1801.
60. Holmes MB, Sobel BE, Howard DB, Schneider DJ. Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications. Thromb Res. 1999;95:75-82.
61. Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: A randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-1243.
62. Goldstein JN, Refaai MA, Milling TJ Jr, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: A phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385:2077-2087.
63. Hanson SR, Griffin JH, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest. 1993;92:2003-2012.
64. Tanaka KA, Esper S, Bolliger D. Perioperative factor concentrate therapy. Br J Anaesth. 2013;111(suppl 1):i35-i49.
65. Ortmann E, Besser MW, Sharples LD, et al. An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg. 2015;121:26-33.
66. Rao VK, Lobato RL, Bartlett B, et al. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28:1221-1226.
67. Song HK, Tibayan FA, Kahl EA, et al. Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery. J Thorac Cardiovasc Surg. 2014;147:1036-1040.
68. Tanaka KA, Mazzeffi MA, Grube M, Ogawa S, Chen EP. Threefactor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion. 2013;53:920-921.
69. Demeyere R, Gillardin S, Arnout J, Strengers PF. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: A randomized study. Vox Sang. 2010;99:251-260.
70. Balsam LB, Timek TA, Pelletier MP. Factor eight inhibitor bypassing activity (FEIBA) for refractory bleeding in cardiac surgery: Review of clinical outcomes. J Card Surg. 2008;23:614-621.
71. Dentali F, Marchesi C, Giorgi Pierfranceschi M, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011;106:429-438.
72. Tanaka K, Moser K, Abraham D, Sniecinski R, Mazzeffi M. Off-label prothrombin complex concentrates: Buyer be careful! J Cardiothorac Vasc Anesth. 2017 [Epub ahead of print].
73. Astermark J, Donfield SM, DiMichele DM, et al; FENOC Study Group. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: The FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2007;109:546-551.
74. Hoffman M, Dargaud Y. Mechanisms and monitoring of bypassing agent therapy. J Thromb Haemost. 2012;10: 1478-1485.
75. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295:293-298.
76. Ekezue BF, Sridhar G, Ovanesov MV, et al. Clotting factor product administration and same-day occurrence of thrombotic events, as recorded in a large healthcare database during 2008-2013. J Thromb Haemost. 2015;13:2168-2179.
77. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810-1852.
78. Denis C, De Kerguennec C, Bernuau J, Beauvais F, Cohen Solal A. Acute hypoxic hepatitis ('liver shock'): Still a frequently overlooked cardiological diagnosis. Eur J Heart Fail. 2004;6:561-565.
79. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS Annual Report: The evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30:115-123.
80. Sen S, Laowatana S, Lima J, Oppenheimer SM. Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events. J Neurol Neurosurg Psychiatry. 2004;75:1421-1425.
81. Cooley BC, Chen CY, Hess R, Schmeling G. Incomplete resolution of deep vein thrombosis under reduced flow conditions. Thromb Res. 2013;131:55-58.
82. Goldhammer JE, Bakowitz MJ, Milas BL, Patel PA. Intracardiac thrombosis after emergent prothrombin complex concentrate administration for warfarin reversal. Anesthesiology. 2015;123:458.
83. McMullan V, Alston RP III. Aprotinin and cardiac surgery: A sorry tale of evidence misused. Br J Anaesth. 2013;110:675-678.
84. Myles PS, Smith JA, Forbes A, et al; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136-148.
85. Warnaar N, Molenaar IQ, Colquhoun SD, et al. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: A systematic review. J Thromb Haemost. 2008;6:297-302.
86. Zhang B, Wieslander JB. Influence of early fibrinolysis inhibition on thrombus formation following microvascular trauma. Microsurgery. 1996;17:278-285.
87. Williams B, McNeil J, Crabbe A, Tanaka KA. Practical use of thromboelastometry in the management of perioperative coagulopathy and bleeding. Transfus Med Rev. 2017;31:11-25.